ABSTRACT

Vaccine Manufacturing in Africa: What it Takes and Why it Matters   [open pdf - 154KB]

From the Executive Summary: "Africa is home to 17 per cent of the world's population but, due to a lack of manufacturing capacity, can currently produce only 1 per cent of its vaccine needs. Only seven African countries have companies operating across the vaccine-manufacturing value chain, and of these, only one - Senegal - exports a WHO [World Health Organization] pre-qualified vaccine; most do not export at all. The uneven distribution of manufacturing and financing capabilities globally has led to an unequal distribution of global access to Covid-19 vaccines, with African countries largely reliant on external suppliers. This dependency is driving delays and uncertainty, which in turn affects governments' abilities to implement vaccine rollouts, protect their populations and ultimately rejoin the global economy. In this paper, we argue that the goal should be transitioning the continent from dependency towards greater self-sufficiency and security of supply. We also make key recommendations for policymakers on how to grow vaccine-manufacturing capacity across Africa."

Author:
Publisher:
Date:
2021-04-01
Series:
Copyright:
2021 Tony Blair Institute for Global Change. Posted here with permission. Documents are for personal use only and not for commercial profit.
Retrieved From:
Tony Blair Institute for Global Change: https://institute.global/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations